Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

[up] Up a level
Number of items: 6.

Mukherjee, Somnath, Hurt, Christopher N. ORCID: https://orcid.org/0000-0003-1206-8355, Adams, Richard ORCID: https://orcid.org/0000-0003-3915-7243, Bateman, Andrew, Bradley, Kevin M. ORCID: https://orcid.org/0000-0003-1911-3382, Bridges, Sarah ORCID: https://orcid.org/0000-0002-7665-5770, Falk, Stephen, Griffiths, Gareth, Gwynne, Sarah, Jones, Christopher M., Markham, Philip J. ORCID: https://orcid.org/0000-0002-6119-0157, Maughan, Tim, Nixon, Lisette S. ORCID: https://orcid.org/0000-0002-1270-6970, Radhakrishna, Ganesh, Roy, Rajarshi, Schoenbuchner, Simon, Sheikh, Hamid, Spezi, Emiliano ORCID: https://orcid.org/0000-0002-1452-8813, Hawkins, Maria and Crosby, Thomas D.L. 2023. Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trial. EClinicalMedicine 61 , 102059. 10.1016/j.eclinm.2023.102059
file

Bridges, Sarah ORCID: https://orcid.org/0000-0002-7665-5770, Lamont‐Robinson, Catherine, Herbert, Allan, Din, Mashmooma, Smith, Carl, Ahmed, Nasra, Ali, Arafa, Bandyopadhyay, Sudipta, Bibi, Saleema, Canu, Rossana, Correia, Mariama N. G., Djalo, Mamadu S., Hayan, Kense, Horne, Alka, Mita, Ayesha and Svobodova, Martina ORCID: https://orcid.org/0000-0001-7949-4039 2023. Talking Trials: An arts‐based exploration of attitudes to clinical trials amongst minority ethnic members of the South Riverside Community of Cardiff. Health Expectations 26 (3) , pp. 1236-1245. 10.1111/hex.13740
file

Bridges, S. ORCID: https://orcid.org/0000-0002-7665-5770, Thomas, B., Radhakrishna, G., Hawkins, M., Holborow, A., Hurt, C. ORCID: https://orcid.org/0000-0003-1206-8355, Mukherjee, S., Nixon, L., Crosby, T. and Gwynne, S. 2022. SCOPE 2 – Still answering the unanswered questions in oesophageal radiotherapy? SCOPE 2: a Randomised phase II/III trial to study radiotherapy dose escalation in patients with oesophageal cancer treated with definitive chemoradiation with an embedded phase II trial for patients with a poor early response using positron emission tomography/computed tomography. Clinical Oncology 34 (7) , E269-E280. 10.1016/j.clon.2022.03.019

Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Mukherjee, Somnath, Bridgewater, John, Falk, Stephen, Crosby, Tom, McDonald, Alec, Joseph, George, Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172, Abrams, Ross A., Blazeby, Jane M., Bridges, Sarah ORCID: https://orcid.org/0000-0002-7665-5770, Dutton, Peter, Griffiths, Gareth, Maughan, Timothy and Johnson, Colin 2015. Health-related quality of life in SCALOP, a randomized Phase 2 trial comparing chemoradiation therapy regimens in locally advanced pancreatic cancer. International Journal of Radiation Oncology Biology Physics 93 (4) , pp. 810-818.
file

Nixon, Lisette Sheena ORCID: https://orcid.org/0000-0002-1270-6970, Mukherjee, S., Wills, L., Millin, T., Bridges, Sarah ORCID: https://orcid.org/0000-0002-7665-5770, Abrams, R. A., Joseph, G., Griffiths, G., Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355 and Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172 2013. The SCALOP Trial Plan Assessment Form (PAF) as a tool for Radiation Therapy Trials Quality Assurance (RTTQA). International Journal of Radiation Oncology*Biology*Physics 87 (2) , S306. 10.1016/j.ijrobp.2013.06.804

Mukherjee, S., Hurt, Chris Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Griffiths, G., Crosby, T. S., Staffurth, John Nicholas ORCID: https://orcid.org/0000-0002-7834-3172, Bridges, Sarah ORCID: https://orcid.org/0000-0002-7665-5770, Bridgewater, J. A., Mcdonald, A., Falk, S. and Maughan, Timothy Stanley 2010. A Cancer Research UK multicenter randomized phase II study of induction chemotherapy followed by gemcitabine- or capecitabine-based chemoradiotherapy for locally advanced nonmetastatic pancreatic cancer. American Journal of Clinical Oncology 28

This list was generated on Tue Apr 16 05:10:37 2024 BST.


Maintained by Cardiff University Information Services